CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells.
about
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.IL-17A and IL-2-expanded regulatory T cells cooperate to inhibit Th1-mediated rejection of MHC II disparate skin grafts.IL-2/α-IL-2 Complex Treatment Cannot Be Substituted for the Adoptive Transfer of Regulatory T cells to Promote Bone Marrow Engraftment.Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.Lessons and limits of mouse models.T regulatory cells in childhood arthritis--novel insights.T-cell costimulatory blockade in organ transplantation.Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?T Cell Cosignaling Molecules in Transplantation.ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys.Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans.Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells.CD4+ CD28-Negative Cells: Armed and Dangerous.Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice.Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells.IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors.Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant.Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade.First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28.Adoptive Cell Therapy with Tregs to Improve Transplant Outcomes: The Promise and the Stumbling Blocks.Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4+CTLA4hi T Cells in Non-Human Primate Renal Allograft Recipients Treated with CD28 Co-Stimulation Blockade.March1-dependent modulation of donor MHC II on CD103 dendritic cells mitigates alloimmunity
P2860
Q33781150-1431D7E5-287A-4810-ABD1-110805EA1926Q33804736-402ED204-F368-4488-B46F-3EA00DBCCF52Q35022593-B97F1DA6-0BBE-467E-B796-D78A5B0CD2CBQ35885490-9341455F-F5C6-4C2E-B308-FD8FFB3B86B0Q36389157-5B50A5EA-5477-4E91-96B7-F2CE2BE96333Q37340373-2C221BFA-A164-4D42-B0ED-60E5A7354754Q38167815-F43CA4BA-8AEC-4458-9CAC-E15078B8FF16Q38168010-2D1263AD-9B96-4162-B16F-EC18E152876DQ38804454-F287AE77-9575-44A7-B95B-F437008E35C7Q38837473-E1DDFA71-B233-4849-AC4C-5FE521EAE5BFQ39419895-D656A49F-CFA5-4FA2-A3B7-58B31361D615Q39782306-EC318D38-CA6E-4EDB-B3DD-8A4EA0103F97Q41822599-81C00468-CA74-4A18-9A56-1CFFED6AF296Q41889471-C5A28A32-896E-4E90-BEF0-50FC18DEA443Q42393633-204AC57C-D830-4125-99AD-2AED7F0509EDQ46122123-E5C21A2E-F135-4D5A-8E8F-867DEF8DB070Q46134547-4D10FFB7-12A0-4A08-B958-71C04EB8B1C2Q47099680-58C5B4A7-EC48-4435-8EFB-BC0978154E2DQ47952891-A3E8DAF7-7B89-4E58-A819-1CC5D6C16F5AQ48204345-C2367F11-8588-4115-B101-EA5C9DA2CA7EQ48223745-90B5DD27-1C9C-4A4A-9D9E-A6254C2EAF29Q50632486-7B5151C8-D577-4755-91B1-B24ED1C223CBQ51742567-3E1FF893-68F5-4E0A-98E7-DF7C8D1A6CC8Q58699588-8BFFB163-2EFF-4D4D-B18E-70A0868B368A
P2860
CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
CTLA4-Ig restores rejection of ...... 2-expanded regulatory T cells.
@en
CTLA4-Ig restores rejection of ...... 2-expanded regulatory T cells.
@nl
type
label
CTLA4-Ig restores rejection of ...... 2-expanded regulatory T cells.
@en
CTLA4-Ig restores rejection of ...... 2-expanded regulatory T cells.
@nl
prefLabel
CTLA4-Ig restores rejection of ...... 2-expanded regulatory T cells.
@en
CTLA4-Ig restores rejection of ...... 2-expanded regulatory T cells.
@nl
P2093
P2860
P1476
CTLA4-Ig restores rejection of ...... 2-expanded regulatory T cells.
@en
P2093
A Le Moine
L-M Charbonnier
P H Lemaître
P2860
P304
P356
10.1111/J.1600-6143.2012.04184.X
P407
P577
2012-07-03T00:00:00Z